Phase II/III Trial of Atezolizumab with Chemotherapy for Advanced Neuroendocrine Carcinomas
A phase II/III trial is evaluating the efficacy of atezolizumab combined with standard chemotherapy in advanced or metastatic neuroendocrine carcinomas originating outside the lung.